Advertisement

Loading...

CanaFarma Hemp Products Corp.

CNFA.CNCNQ
Healthcare
Drug Manufacturers - Specialty & Generic
$0.05
$0.00(0.00%)
Canadian Market opens in 16h 33m

CanaFarma Hemp Products Corp. (CNFA.CN) Stock Competitors & Peer Comparison

See (CNFA.CN) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
CNFA.CNCA$0.05+0.00%9.8M-0.83-CA$0.06N/A
CURA.CNCA$5.22+9.21%4.1B-6.07-CA$0.86N/A
BHC.TOCA$6.99-1.27%2.6B12.05CA$0.58N/A
VRNO.CNCA$6.32+6.76%2.2B-5.40-CA$1.17N/A
CURA.TOCA$2.77-7.05%2.1B-6.30-CA$0.44N/A
GTII.CNCA$8.01-5.76%1.9B12.12CA$0.66N/A
CRON.TOCA$3.48-0.85%1.3B-116.00-CA$0.03N/A
TRUL.CNCA$7.40-6.45%1.2B-9.13-CA$0.80N/A
TLRY.TOCA$8.80-2.98%891M-0.27-CA$32.31N/A
TER.CNCA$2.38-0.42%804.8M-1.33-CA$1.79N/A
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

CNFA.CN vs CURA.CN Comparison April 2026

CNFA.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNFA.CN stands at 9.8M. In comparison, CURA.CN has a market cap of 4.1B. Regarding current trading prices, CNFA.CN is priced at CA$0.05, while CURA.CN trades at CA$5.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNFA.CN currently has a P/E ratio of -0.83, whereas CURA.CN's P/E ratio is -6.07. In terms of profitability, CNFA.CN's ROE is -7.84%, compared to CURA.CN's ROE of -0.28%. Regarding short-term risk, CNFA.CN is less volatile compared to CURA.CN. This indicates potentially lower risk in terms of short-term price fluctuations for CNFA.CN.Check CURA.CN's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions